Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001968822-23-000001
Filing Date
2023-03-13
Accepted
2023-03-13 16:04:38
Documents
1
Effectiveness Date
2023-03-13
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 10550
  Complete submission text file 0001968822-23-000001.txt   11618
Mailing Address 1361 AMSTERDAM AVENUE SUITE 520 NEW YORK NY 10027
Business Address 1361 AMSTERDAM AVENUE SUITE 520 NEW YORK NY 10027 646-344-1248
Volastra Therapeutics, Inc. (Filer) CIK: 0001968822 (see all company filings)

EIN.: 841816753 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-475679 | Film No.: 23727295